• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
An amphipathic motif at the transmembrane-cytoplasmic junction prevents autonomous activation of the thrombopoietin receptor.跨膜-细胞质交界处的一个两亲性基序可防止血小板生成素受体的自主激活。
Blood. 2006 Mar 1;107(5):1864-71. doi: 10.1182/blood-2005-06-2600. Epub 2005 Oct 25.
2
Janus kinases affect thrombopoietin receptor cell surface localization and stability.Janus激酶影响血小板生成素受体的细胞表面定位和稳定性。
J Biol Chem. 2005 Jul 22;280(29):27251-61. doi: 10.1074/jbc.M501376200. Epub 2005 May 16.
3
Role of the distal half of the c-Mpl intracellular domain in control of platelet production by thrombopoietin in vivo.c-Mpl细胞内结构域远端一半在体内血小板生成素控制血小板生成中的作用。
Mol Cell Biol. 2000 Jan;20(2):507-15. doi: 10.1128/MCB.20.2.507-515.2000.
4
A novel MPL point mutation resulting in thrombopoietin-independent activation.一种导致血小板生成素非依赖性激活的新型MPL点突变。
Leukemia. 2002 Aug;16(8):1500-6. doi: 10.1038/sj.leu.2402554.
5
Control of thrombopoietin-induced megakaryocytic differentiation by the mitogen-activated protein kinase pathway.丝裂原活化蛋白激酶途径对血小板生成素诱导的巨核细胞分化的调控
Mol Cell Biol. 1997 Sep;17(9):4991-5000. doi: 10.1128/MCB.17.9.4991.
6
Lnk inhibits Tpo-mpl signaling and Tpo-mediated megakaryocytopoiesis.Lnk抑制血小板生成素-巨核细胞系生长因子信号传导以及血小板生成素介导的巨核细胞生成。
J Exp Med. 2004 Sep 6;200(5):569-80. doi: 10.1084/jem.20040762. Epub 2004 Aug 30.
7
Synergistic effects on erythropoiesis, thrombopoiesis, and stem cell competitiveness in mice deficient in thrombopoietin and steel factor receptors.血小板生成素和Steel因子受体缺陷小鼠中对红细胞生成、血小板生成及干细胞竞争力的协同作用
Blood. 2004 Sep 1;104(5):1306-13. doi: 10.1182/blood-2004-04-1522. Epub 2004 May 11.
8
Thrombopoietin, but not cytokines binding to gp130 protein-coupled receptors, activates MAPKp42/44, AKT, and STAT proteins in normal human CD34+ cells, megakaryocytes, and platelets.血小板生成素,而非与gp130蛋白偶联受体结合的细胞因子,可激活正常人CD34+细胞、巨核细胞和血小板中的MAPKp42/44、AKT及STAT蛋白。
Exp Hematol. 2002 Jul;30(7):751-60. doi: 10.1016/s0301-472x(02)00810-x.
9
Regulation of megakaryocytopoiesis by thrombopoietin and stromal cells.血小板生成素和基质细胞对巨核细胞生成的调控。
Leukemia. 1997 Apr;11 Suppl 3:435-8.
10
The thrombopoietin receptor c-MPL activates JAK2 and TYK2 tyrosine kinases.血小板生成素受体c-MPL激活JAK2和TYK2酪氨酸激酶。
Exp Hematol. 1995 Aug;23(9):1040-8.

引用本文的文献

1
A review on the functional characteristics of the c-Myeloproliferative Leukaemia (c-MPL) gene and its isoforms.关于 c-Myeloproliferative Leukaemia (c-MPL) 基因及其异构体的功能特征的综述。
Cell Oncol (Dordr). 2024 Oct;47(5):1607-1626. doi: 10.1007/s13402-024-00988-w. Epub 2024 Sep 16.
2
Cryo-EM structure of the extracellular domain of murine Thrombopoietin Receptor in complex with Thrombopoietin.冷冻电镜结构解析鼠类血小板生成素受体胞外结构域与血小板生成素复合物
Nat Commun. 2024 Feb 7;15(1):1135. doi: 10.1038/s41467-024-45356-2.
3
Constitutive activation and oncogenicity are mediated by loss of helical structure at the cytosolic boundary of thrombopoietin receptor mutant dimers.构象激活和致癌性是由血小板生成素受体突变二聚体胞质边界螺旋结构缺失介导的。
Elife. 2023 Jun 20;12:e81521. doi: 10.7554/eLife.81521.
4
Effects of calreticulin mutations on cell transformation and immunity.钙网织蛋白突变对细胞转化和免疫的影响。
J Cell Mol Med. 2023 Apr;27(8):1032-1044. doi: 10.1111/jcmm.17713. Epub 2023 Mar 13.
5
Essential thrombocythaemia progression to the fibrotic phase is associated with a decrease in JAK2 and PDL1 levels.原发性血小板增多症向纤维化期进展与 JAK2 和 PDL1 水平降低有关。
Ann Hematol. 2022 Dec;101(12):2665-2677. doi: 10.1007/s00277-022-05001-8. Epub 2022 Oct 21.
6
JAK inhibitors and COVID-19.JAK 抑制剂与 COVID-19。
J Immunother Cancer. 2022 Apr;10(4). doi: 10.1136/jitc-2021-002838.
7
MPL S505C enhances driver mutations at W515 in essential thrombocythemia.MPL S505C增强原发性血小板增多症中W515位点的驱动突变。
Blood Cancer J. 2021 Nov 29;11(11):188. doi: 10.1038/s41408-021-00583-4.
8
In and out: Traffic and dynamics of thrombopoietin receptor.进出:血小板生成素受体的运输和动力学。
J Cell Mol Med. 2021 Oct;25(19):9073-9083. doi: 10.1111/jcmm.16878. Epub 2021 Aug 27.
9
Integration of Molecular Information in Risk Assessment of Patients with Myeloproliferative Neoplasms.整合分子信息于骨髓增殖性肿瘤患者的风险评估中。
Cells. 2021 Aug 2;10(8):1962. doi: 10.3390/cells10081962.
10
Synoptic Diagnostics of Myeloproliferative Neoplasms: Morphology and Molecular Genetics.骨髓增殖性肿瘤的概要诊断:形态学与分子遗传学
Cancers (Basel). 2021 Jul 14;13(14):3528. doi: 10.3390/cancers13143528.

本文引用的文献

1
An electrostatic engine model for autoinhibition and activation of the epidermal growth factor receptor (EGFR/ErbB) family.一种用于表皮生长因子受体(EGFR/ErbB)家族自抑制和激活的静电引擎模型。
J Gen Physiol. 2005 Jul;126(1):41-53. doi: 10.1085/jgp.200509274. Epub 2005 Jun 13.
2
Janus kinases affect thrombopoietin receptor cell surface localization and stability.Janus激酶影响血小板生成素受体的细胞表面定位和稳定性。
J Biol Chem. 2005 Jul 22;280(29):27251-61. doi: 10.1074/jbc.M501376200. Epub 2005 May 16.
3
Helix packing and orientation in the transmembrane dimer of gp55-P of the spleen focus forming virus.脾脏灶性形成病毒gp55-P跨膜二聚体中的螺旋堆积与取向
Biophys J. 2005 Aug;89(2):1194-202. doi: 10.1529/biophysj.104.057844. Epub 2005 May 13.
4
G-CSF receptor truncations found in SCN/AML relieve SOCS3-controlled inhibition of STAT5 but leave suppression of STAT3 intact.在严重先天性中性粒细胞减少症/急性髓系白血病中发现的粒细胞集落刺激因子受体截短可缓解细胞因子信号传导抑制因子3对信号转导和转录激活因子5的控制抑制作用,但对信号转导和转录激活因子3的抑制作用保持不变。
Blood. 2004 Aug 1;104(3):667-74. doi: 10.1182/blood-2003-08-2913. Epub 2004 Apr 6.
5
Familial essential thrombocythemia associated with a dominant-positive activating mutation of the c-MPL gene, which encodes for the receptor for thrombopoietin.家族性原发性血小板增多症与c-MPL基因的显性阳性激活突变相关,该基因编码血小板生成素的受体。
Blood. 2004 Jun 1;103(11):4198-200. doi: 10.1182/blood-2003-10-3471. Epub 2004 Feb 5.
6
Differential signalling of NH2-terminal flag-labelled thrombopoietin receptor activated by TPO or anti-FLAG antibodies.由血小板生成素(TPO)或抗FLAG抗体激活的NH2末端FLAG标记的血小板生成素受体的差异信号传导。
Cell Signal. 2004 Mar;16(3):355-63. doi: 10.1016/j.cellsig.2003.08.010.
7
Active and inactive orientations of the transmembrane and cytosolic domains of the erythropoietin receptor dimer.促红细胞生成素受体二聚体跨膜结构域和胞质结构域的活性与非活性取向。
Mol Cell. 2003 Nov;12(5):1239-50. doi: 10.1016/s1097-2765(03)00389-7.
8
Prominent role of TGF-beta 1 in thrombopoietin-induced myelofibrosis in mice.转化生长因子-β1在血小板生成素诱导的小鼠骨髓纤维化中的显著作用。
Blood. 2002 Nov 15;100(10):3495-503. doi: 10.1182/blood-2002-04-1133. Epub 2002 Jul 5.
9
The cytoplasmic domain of Mpl receptor transduces exclusive signals in embryonic and fetal hematopoietic cells.Mpl受体的胞质结构域在胚胎和胎儿造血细胞中传导独特的信号。
Blood. 2002 Sep 15;100(6):2063-70.
10
A novel MPL point mutation resulting in thrombopoietin-independent activation.一种导致血小板生成素非依赖性激活的新型MPL点突变。
Leukemia. 2002 Aug;16(8):1500-6. doi: 10.1038/sj.leu.2402554.

跨膜-细胞质交界处的一个两亲性基序可防止血小板生成素受体的自主激活。

An amphipathic motif at the transmembrane-cytoplasmic junction prevents autonomous activation of the thrombopoietin receptor.

作者信息

Staerk Judith, Lacout Catherine, Sato Takeshi, Smith Steven O, Vainchenker William, Constantinescu Stefan N

机构信息

Ludwig Institute for Cancer Research, Université catholique de Louvain, Avenue Hippocrate 74, UCL 75-4, 1200 Brussels, Belgium.

出版信息

Blood. 2006 Mar 1;107(5):1864-71. doi: 10.1182/blood-2005-06-2600. Epub 2005 Oct 25.

DOI:10.1182/blood-2005-06-2600
PMID:16249382
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1379661/
Abstract

Ligand binding to the thrombopoietin receptor (TpoR) is thought to impose a dimeric receptor conformation(s) leading to hematopoietic stem cell renewal, megakaryocyte differentiation, and platelet formation. Unlike other cytokine receptors, such as the erythropoietin receptor, TpoR contains an amphipathic KWQFP motif at the junction between the transmembrane (TM) and cytoplasmic domains. We show here that a mutant TpoR (delta5TpoR), where this sequence was deleted, is constitutively active. In the absence of ligand, delta5TpoR activates Jak2, Tyk2, STAT5, and mitogen-activated protein (MAP) kinase, but does not appear to induce STAT3 phosphorylation. Delta5TpoR induces hematopoietic myeloid differentiation in the absence of Tpo. In the presence of Tpo, the delta5TpoR mutant appears to enhance erythroid differentiation when compared with the Tpo-activated wild-type TpoR. Strikingly, individual substitution of K507 or W508 to alanine also induces constitutive TpoR activation, indicating that the K and W residues within the amphipathic KWQFP motif are crucial for maintaining the unliganded receptor inactive. These residues may be targets for activating mutations in humans. Such a motif may exist in other receptors to prevent ligand-independent activation and to allow signaling via multiple flexible interfaces.

摘要

配体与血小板生成素受体(TpoR)结合被认为会诱导二聚体受体构象,从而导致造血干细胞更新、巨核细胞分化和血小板形成。与其他细胞因子受体不同,如促红细胞生成素受体,TpoR在跨膜(TM)和细胞质结构域之间的连接处含有一个两亲性KWQFP基序。我们在此表明,缺失该序列的突变型TpoR(delta5TpoR)具有组成性活性。在没有配体的情况下,delta5TpoR激活Jak2、Tyk2、STAT5和丝裂原活化蛋白(MAP)激酶,但似乎不会诱导STAT3磷酸化。Delta5TpoR在没有Tpo的情况下诱导造血髓系分化。与Tpo激活的野生型TpoR相比,在有Tpo的情况下,delta5TpoR突变体似乎增强了红系分化。引人注目的是,将K507或W508单独替换为丙氨酸也会诱导TpoR组成性激活,表明两亲性KWQFP基序中的K和W残基对于维持未结合配体的受体无活性至关重要。这些残基可能是人类激活突变的靶点。这样的基序可能存在于其他受体中,以防止非配体依赖性激活,并允许通过多个灵活界面进行信号传导。